CLDX vs PLTR · rev $37.0K vs P/E 584, rev $3.57B
Celldex Therapeutics Inc (CLDX) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
CLDX currently screens at market cap $2.35B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the CLDX and PLTR stock pages for the full models.
Not investment advice.